AzTrials
AzTrials

PsychotherapyNCT03453957

Therapeutic Alliance Tensions and Repair in Psychotherapy Practices

A study testing Professional development program in people with Psychotherapy and Therapeutic Alliance, run by University of Ottawa at 2 sites in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates a professional development program intended to improve the relationship or alliance between therapists and patients/clients who are receiving psychotherapy in the community. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Psychotherapy, Therapeutic Alliance
What is being tested?
Professional development program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
84 participants
Where
2 sitesCanada
Study dates
1 Feb 2018to 14 Aug 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • regulated health professional
  • in good standing with a Canadian provincial regulatory college
  • scope of practice includes psychotherapy
  • ability to add 3 or more new, English speaking clients to caseload over 6 to 9 months
  • ability to obtain timely permission to conduct research from therapist's employing institution or health group when applicable
  • 18 years of age or older
  • will participate in psychotherapy sessions in English
  • will see the study-affiliated therapist for a minimum of 6 sessions in the next 6 months

Who cannot join

  • none
  • Patient/Client
  • already seeing another therapist
  • diagnosed with a neurocognitive disorder
  • diagnosed with a psychotic disorder
  • expressed suicidal behaviour in the past six months as assessed by their participating therapist

Trial locations and contacts

2 sites in 1 country.

Canada2 sites
  • University of Ottawa

    Ottawa, Ontario, K1N 6N5

  • Mt. Sinai Hospital

    Toronto, Ontario, M5G 1X5

Other trials in Canada

About this study

Official title: Therapeutic Alliance Tensions and Repair in Psychotherapy Practices: A Psychotherapy Practice Research Network (PPRNet) Study

This study evaluates a professional development program intended to improve the relationship or alliance between therapists and patients/clients who are receiving psychotherapy in the community. Half of the participating therapists will receive training to detect and improve alliance with new patients while half will not. The professional development training is expected to improve therapists effectiveness in identifying and correcting alliance tensions which will, in turn, improve therapeutic outcomes for patients/clients.

Read the detailed description

Psychotherapy is the treatment of choice for many mental disorders, yet there is a gap between research and practice. Research indicates that: the therapist-patient alliance is important to reduce patient symptoms, alliance tensions are detrimental to patients, and those therapists who identify and repair alliance tensions can improve patient outcomes. In this study we will use state of the art research to train community-based therapists in evidence-based interventions to identify and repair alliance tensions. Trained therapists and their patients will be compared to therapists who provide usual care to their patients. Improvement in therapists' skills in identifying and repairing alliance tensions and how this is associated with better patient mental health outcomes will be measured. Trained therapists will be interviewed to identify the best ways of improving the training and disseminating the findings to psychotherapists across Canada. Research to improve practicing therapists' ability to identify and repair therapeutic alliance tensions will result in better mental health outcomes for patients.

Being tested
Professional development program
Keywords
Practice based research

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Professional development programOther

    Professional development program consists of training including workshops and consultation sessions to enhance therapists ability to detect and repair alliance ruptures in active community based psychotherapy.

Study groups in NCT03453957
Study groupRoleWhat they receive
Professional Development ProgramExperimentalTherapists who participate in workshops and consultation sessions with study trainers during study-related therapy sessions and their participating patients/clients.
Receives: Other: Professional development program
ControlNo interventionTherapists who did not participate in workshops and consultations sessions while engaging in study-related therapy sessions and their participating patients/clients.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean tension resolution rating scale

    The Rupture Resolution Rating System (3RS) is an observer-based measure to identify alliance tensions and resolution processes. Independent blind reliable trained judges will rate video recordings of 6 psychotherapy session recorded with participating clients. A mean tension score will be assigned per client which will be the average of the 6 session scores.

    score ranges from 1 (withdrawal/confrontation rupture(s) did not occur; not significant for the alliance) to 5 (withdrawal/confrontation rupture(s) occurred; significant for the alliance).

    Measured: 6 therapy sessions over 6 weeks up to 6 months depending on the frequency of therapy

Secondary outcomes (2)
  1. Generalized Anxiety Disorder 7-item scale (GAD-7) change from baseline

    Self-report measurement of severity of anxiety using the GAD-7 scale. A change in anxiety scores will be assess following 6 therapy session with data collected before therapy(baseline) and again after all 6 sessions of therapy have been completed. Scores range from 0 (low anxiety) to 27 (high anxiety) with scores over 10 being of clinical significance.

    Measured: baseline and end of 6 therapy sessions, 6 weeks to 6 months depending on the frequency of therapy

  2. Patient Health Questionnaire 9-item scale (PHQ-9) change from baseline

    Self-report measurement of depression symptoms using the PHQ-9 scale. A change in depression symptom scores will be assess following 6 therapy session with data collected before therapy and again after all 6 sessions of therapy have been completed. Scores range from 0 (low) to 27 (high) with scores over 10 being of clinical significance.

    Measured: baseline and end of 6 therapy sessions, 6 weeks to 6 months depending on the frequency of therapy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Mar 2018
  2. Study start1 Feb 2018
  3. Primary completion14 May 2021
  4. Study completion14 Aug 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This will be a 2-arm, parallel, prospective, single-blind cluster RCT with 1-1 allocation comparing: (a) therapists who receive the professional development intervention to identify and repair alliance tensions at the study outset versus (b) therapists who receive the intervention after participation is complete (no training control). Therapists will be randomized to study condition and patients will be clustered within therapists. Randomization will control for: (a) the effect of therapist variables (age, gender, theoretical orientation, experience, differing initial skill level) on competence, therapeutic alliance, or patient outcomes; (b) potential biases caused by pre-treatment patient variables (symptom severity, co-morbidity, chronicity, psychoactive medications); and (c) treatment or study factors (e.g. frequency of sessions, time to complete the study sessions, treatment received after the study sessions). Patients will be blind to therapist study arm allocation.
Masking
Single blind
Who is masked
Participant
Enrolment
84 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03453957
Sponsor's protocol ID
363733
Status last verified
Jun 2022
First submitted
16 Feb 2018
Last updated
1 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Professional development program in people with Psychotherapy and Therapeutic Alliance, run by University of Ottawa at 2 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean tension resolution rating scale (time frame: 6 therapy sessions over 6 weeks up to 6 months depending on the frequency of therapy). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in